<SEC-DOCUMENT>0001144204-16-097908-index.html : 20160429
<SEC-HEADER>0001144204-16-097908.hdr.sgml : 20160429
<ACCEPTANCE-DATETIME>20160429170848
ACCESSION NUMBER:		0001144204-16-097908
CONFORMED SUBMISSION TYPE:	10-K/A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20151231
FILED AS OF DATE:		20160429
DATE AS OF CHANGE:		20160429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IMMUNE PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001208261
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				521841431
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36602
		FILM NUMBER:		161608099

	BUSINESS ADDRESS:	
		STREET 1:		430 EAST 29TH STREET
		STREET 2:		SUITE 940
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016
		BUSINESS PHONE:		646-440-9310

	MAIL ADDRESS:	
		STREET 1:		430 EAST 29TH STREET
		STREET 2:		SUITE 940
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EPICEPT CORP
		DATE OF NAME CHANGE:	20021129
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K/A
<SEQUENCE>1
<FILENAME>v438378_10ka.htm
<DESCRIPTION>10-K/A
<TEXT>
Document 1 - file: v438378_10ka.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>v438378_ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
Document 2 - file: v438378_ex31-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>v438378_ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
Document 3 - file: v438378_ex31-2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>v438378_ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
Document 4 - file: v438378_ex32-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>v438378_ex32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
Document 5 - file: v438378_ex32-2.htm

</DOCUMENT>
</SEC-DOCUMENT>